NCT07787247|Recruiting
Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
ROME-MG
Pilot Study: Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
Loading search results
ROME-MG
Pilot Study: Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
Sponsor study identifier
Secondary identifiers
OTHER_GRANT · EMD Serono
OTHER · GWU IRB
OTHER · GWU
observational
18
1 country
1
Study Start
August 19, 2026
Actual (reported)Primary Completion
October 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
October 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Myasthenia gravis is an autoimmune neuromuscular disorder characterized by fluctuating weakness, which can worsen suddenly without a clear predictor. The hypothesis is that continuous monitoring of key aspects of patient physiology and activity coupled to rigorous telemedicine-performed examination has the potential to detect MG worsening which requires change in treatment with the benefit of avoiding need for hospitalization or emergent therapy. This study is to evaluate the reliability of the technology and patient compliance to the monitoring program
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 17, 2026
Actual (reported)August 19, 2026
Actual (reported)August 26, 2026
Actual (reported)October 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
October 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Subject Study Completion
Proportion of subjects complete the 12-month study
12 months
Datasets retrieved from study assessments
Proportion of assessments provide data sets that can be analyzed
12 months
Subject Satisfaction
12 months
Myasthenia Gravis-Activities of Daily Living and Myasthenia Gravis-Core Examination
12 months
Fitbit correlation
12 months
Hospital Anxiety and Depression Scale
12 months
Myasthenia Gravis Patients who satisfy the study's eligibility criteria
The George Washington University
Washington D.C., District of Columbia, 20037, United States
Garbey M, Lesport Q, Girma H, Oztosun G, Abu-Rub M, Guidon AC, Juel V, Nowak RJ, Soliven B, Aban I, Kaminski HJ. Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination. Front Neurol. 2024 Dec 4;15:1474884. doi: 10.3389/fneur.2024.1474884. eCollection 2024.
First Submitted
August 17, 2026
First Posted
August 26, 2026
Study Start
August 19, 2026
Actual (reported)Primary Completion
October 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis
Contact the study team to confirm eligibility.
Study Completion
October 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 5, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: